No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Turnstone Biologics Corp : BofA Global Research Cuts Price Objective to $0.40 From $0.50
BofA Securities Downgrades Turnstone Biologics(TSBX.US) to Sell Rating, Cuts Target Price to $0.4
Leerink Partners Maintains Turnstone Biologics(TSBX.US) With Hold Rating
Turnstone Biologics Faces Financial and Operational Challenges
Turnstone Biologics | 10-Q: Q3 2024 Earnings Report
Turnstone Biologics | 8-K: Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights